Biocon is engaged in the business of manufacture of biotechnology products and research services.
Financial Results:
Biocon Ltd reported Revenues for Q3FY24 of ₹3,954.00 Crores up from ₹2,941.00 Crore year on year, a rise of 34.44%.
Total Expenses for Q3FY24 of ₹3,732.00 Crores up from ₹2,773.00 Crores year on year, a rise of 34.58%.
Consolidated Net Profit of ₹753.00 Crores from -₹21.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹5.50, from -₹0.35 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.